Authors:
LECESNE A
JUDSON J
CROWTHER D
SOMERS R
TURSZ T
KEIZER J
VANHOESEL D
BLAY Y
FRISCH J
VANGLABBEKE M
VANOOSTEROM AT
VERWEIJ J
Citation: A. Lecesne et al., IS OBTENTION OF PARTIAL-RESPONSE (PR) IN FRONT-LINE CHEMOTHERAPY CRITICAL TO IMPROVE OUTCOME OF METASTATIC SOFT-TISSUE SARCOMA (MSTS) PATIENTS (PTS), Annals of oncology, 9, 1998, pp. 556-556
Authors:
DOMENGE C
LECESNE A
PAUTIER P
KRAMAR A
LECHEVALIER T
BOUVET N
THILL L
ESCUDIER B
Citation: C. Domenge et al., ALL-TRANS-RETINOIC ACID (ATRA) + - ALPHA-INTERFERON (IFN) IN SQUAMOUS-CELL CARCINOMA (SCC) - A RANDOMIZED PHASE-II STUDY/, Annals of oncology, 9, 1998, pp. 623-623
Authors:
LLOMBARTCUSSAC A
PIVOT X
RHORALVARADO A
LECESNE A
LECHEVALIER T
TURSZ T
SPIELMANN M
Citation: A. Llombartcussac et al., FIRST-LINE VINORELBINE-MITOXANTRONE COMBINATION IN METASTATIC BREAST-CANCER PATIENTS RELAPSING AFTER AN ADJUVANT ANTHRACYCLINE REGIMEN - RESULTS OF A PHASE-II STUDY, Oncology, 55(5), 1998, pp. 384-390
Authors:
GIRARD P
SPAGGIARI L
BALDEYROU P
LECHEVALIER T
LECESNE A
ESCUDIER B
FILAIRE M
GRUNENWALD D
Citation: P. Girard et al., SHOULD THE NUMBER OF PULMONARY METASTASES INFLUENCE THE SURGICAL DECISION, European journal of cardio-thoracic surgery, 12(3), 1997, pp. 385-391
Authors:
BONVALOT S
DUBE P
LECESNE A
ELIAS D
TERRIER P
VANEL D
LASSER P
GENIN J
Citation: S. Bonvalot et al., SURGICAL-MANAGEMENT OF PRIMARY AND RECURRENT SOFT-TISSUE SARCOMAS OF THE RETROPERITONEUM, European journal of cancer, 33, 1997, pp. 487-487
Authors:
TURSZ T
LECESNE A
BALDEYROU P
GAUTIER E
OPOLON P
GRUNENWALD D
FARACE F
ZITVOGEL L
ESCUDIER B
SCHATZ C
COURTNEY M
LECHEVALIER T
Citation: T. Tursz et al., INTRATUMOR (IT) GENE-TRANSFER WITH RECOMBINANT ADENOVIRAL (RAD) VECTORS IN LUNG-CANCER (LC) PATIENTS (PTS) - THE INSTITUT-GUSTAVE-ROUSSY (IGR) EXPERIENCE, European journal of cancer, 33, 1997, pp. 602-602
Authors:
ESCUDIER B
LECESNE A
FARACE F
GAUTIER E
SAULNIER P
ZITVOGEL L
SCHATZ C
LAMY D
LECHEVALIER T
TURSZ T
Citation: B. Escudier et al., GENE-THERAPY WITH RECOMBINANT ADENOVIRUS IN LUNG-CANCER - FINAL RESULTS OF THE FRENCH PHASE-I STUDY, Cancer gene therapy, 4(6), 1997, pp. 35-35
Authors:
VANEL D
MISSENARD G
LECESNE A
GUINEBRETIERE JM
Citation: D. Vanel et al., RED MARROW RECOLONIZATION INDUCED BY GROWTH-FACTORS MIMICKING AN INCREASE IN TUMOR VOLUME DURING PREOPERATIVE CHEMOTHERAPY - MR STUDY, Journal of computer assisted tomography, 21(4), 1997, pp. 529-531
Authors:
GAHERYSEGARD H
MOLINIERFRENKEL V
LEBOULAIRE C
SAULNIER P
OPOLON P
LENGAGNE R
GAUTIER E
LECESNE A
ZITVOGEL L
VENET A
SCHATZ C
COURTNEY M
LECHEVALIER T
TURSZ T
GUILLET JG
FARACE F
Citation: H. Gaherysegard et al., PHASE-I TRIAL OF RECOMBINANT ADENOVIRUS GENE-TRANSFER IN LUNG-CANCER - LONGITUDINAL-STUDY OF THE IMMUNE-RESPONSES TO TRANSGENE AND VIRAL PRODUCTS, The Journal of clinical investigation, 100(9), 1997, pp. 2218-2226
Authors:
LECESNE A
ARRIAGADA R
GRUNENWALD D
BALDEYROU P
GIRARD P
BRETEL JJ
LECHEVALIER T
Citation: A. Lecesne et al., THERAPEUTIC OPTIONS AND INNOVATIVE APPROACHES IN INOPERABLE LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER (STAGE IIIB), Bulletin du cancer, 84(4), 1997, pp. 413-419
Authors:
FIZAZI K
FARHAT F
THEODORE C
RIXE O
LECESNE A
COMOY E
LECHEVALIER T
Citation: K. Fizazi et al., CA125 AND NEURON-SPECIFIC ENOLASE (NSE) AS TUMOR-MARKERS FOR INTRAABDOMINAL DESMOPLASTIC SMALL ROUND-CELL TUMORS, British Journal of Cancer, 75(1), 1997, pp. 76-78
Authors:
TURSZ T
LECESNE A
BALDEYROU P
GAUTIER E
OPOLON P
SCHATZ C
PAVIRANI A
COURTNEY M
LAMY D
RAGOT T
SAULNIER P
ANDREMONT A
MONIER R
PERRICAUDET M
LECHEVALIER T
Citation: T. Tursz et al., PHASE-I STUDY OF A RECOMBINANT ADENOVIRUS-MEDIATED GENE-TRANSFER IN LUNG-CANCER PATIENTS, Journal of the National Cancer Institute, 88(24), 1996, pp. 1857-1863
Authors:
FIZAZI K
LECESNE A
DOHOLLOU N
AFFAIED S
SPIELMANN M
LECHEVALIER T
Citation: K. Fizazi et al., SERUM NEURON-SPECIFIC ENOLASE (NSE) AS A TUMOR-MARKER FOR THE EWINGS-SARCOMA FAMILY OF TUMORS, European journal of cancer, 32A(10), 1996, pp. 1823-1824
Authors:
BLAY JY
CHAUVIN F
LECESNE A
ANGLARET B
BOUHOUR D
LASSET C
FREYER G
PHILIP T
BIRON P
Citation: Jy. Blay et al., EARLY LYMPHOPENIA AFTER CYTOTOXIC CHEMOTHERAPY AS A RISK FACTOR FOR FEBRILE NEUTROPENIA, Journal of clinical oncology, 14(2), 1996, pp. 636-643
Authors:
ELIAS D
FARACE F
TRIEBEL F
HATTCHOUEL JM
PIGNON JP
LECESNE A
ROUGIER P
LASSER P
DUVILLARD P
ESCUDIER B
Citation: D. Elias et al., PHASE I-II RANDOMIZED STUDY ON PREHEPATECTOMY RECOMBINANT INTERLEUKIN-2 IMMUNOTHERAPY IN PATIENTS WITH METASTATIC CARCINOMA OF THE COLON AND RECTUM, Journal of the American College of Surgeons, 181(4), 1995, pp. 303-310
Authors:
ANGEVIN E
VALTEAUCOUANET D
FARACE F
DIETRICH PY
LECESNE A
TRIEBEL F
ESCUDIER B
Citation: E. Angevin et al., PHASE-I STUDY OF PROLONGED LOW-DOSE SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 (IL-2) IN PATIENTS WITH ADVANCED CANCER, Journal of immunotherapy with emphasis on tumor immunology, 18(3), 1995, pp. 188-195
Authors:
LECESNE A
VASSAL G
FARACE F
SPIELMANN M
LECHEVALIER T
TURSZ T
ESCUDIER B
Citation: A. Lecesne et al., CONCOMITANT INTERLEUKIN-2-DOXORUBICIN (ADR) SCHEDULE IN PATIENTS (PTS) WITH ADVANCED SOFT-TISSUE SARCOMAS (ASTS) - A PHARMACOKINETIC STUDY, European journal of cancer, 31A, 1995, pp. 586-586
Citation: A. Lecesne et al., DEALING WITH INITIAL CHEMOTHERAPY DOSES - A NEW BASIS FOR TREATMENT OPTIMIZATION IN LIMITED SMALL-CELL LUNG-CANCER, Annals of oncology, 6, 1995, pp. 53-56
Authors:
LECESNE A
ANTOINE E
SPIELMANN M
LECHEVALIER T
BRAIN E
TOUSSAINT C
JANIN N
KAYITALIRE L
FONTAINE F
GENIN J
VANEL D
CONTESSO G
TURSZ T
Citation: A. Lecesne et al., HIGH-DOSE IFOSFAMIDE - CIRCUMVENTION OF RESISTANCE TO STANDARD-DOSE IFOSFAMIDE IN ADVANCED SOFT-TISSUE SARCOMAS, Journal of clinical oncology, 13(7), 1995, pp. 1600-1608